Yang K, Zhang J, Feng M, Yao K, Liu Y, Zhou M
Front Aging Neurosci. 2024; 16:1445470.
PMID: 39634655
PMC: 11615878.
DOI: 10.3389/fnagi.2024.1445470.
Netzer W, Sinha A, Ghias M, Chang E, Gindinova K, Mui E
Front Chem. 2024; 12:1381205.
PMID: 39439934
PMC: 11493595.
DOI: 10.3389/fchem.2024.1381205.
Azam H, Rossling R, Geithe C, Khan M, Dinter F, Hanack K
Front Mol Neurosci. 2024; 17:1386735.
PMID: 38883980
PMC: 11177777.
DOI: 10.3389/fnmol.2024.1386735.
Abdallah A
RSC Adv. 2024; 14(16):11057-11088.
PMID: 38586442
PMC: 10995770.
DOI: 10.1039/d3ra08333k.
Kumar J, Shankar G, Kumar S, Thomas J, Singh N, Srikrishna S
Mol Divers. 2023; 28(3):1439-1458.
PMID: 37351693
DOI: 10.1007/s11030-023-10667-x.
Exploring the ATN classification system using brain morphology.
Heinzinger N, Maass A, Berron D, Yakupov R, Peters O, Fiebach J
Alzheimers Res Ther. 2023; 15(1):50.
PMID: 36915139
PMC: 10009950.
DOI: 10.1186/s13195-023-01185-x.
The Pursuit of the "Inside" of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer's Disease?.
Takasugi N, Komai M, Kaneshiro N, Ikeda A, Kamikubo Y, Uehara T
Cells. 2023; 12(3).
PMID: 36766796
PMC: 9914381.
DOI: 10.3390/cells12030454.
BACE1 Inhibitors for Alzheimer's Disease: The Past, Present and Any Future?.
Bazzari F, Bazzari A
Molecules. 2022; 27(24).
PMID: 36557955
PMC: 9785888.
DOI: 10.3390/molecules27248823.
Therapeutics of Alzheimer's Disease: Recent Developments.
Burns S, Selman A, Sehar U, Rawat P, Reddy A, Reddy P
Antioxidants (Basel). 2022; 11(12).
PMID: 36552610
PMC: 9774459.
DOI: 10.3390/antiox11122402.
Expression of Amyloid Precursor Protein, Caveolin-1, Alpha-, Beta-, and Gamma-Secretases in Penumbra Cells after Photothrombotic Stroke and Evaluation of Neuroprotective Effect of Secretase and Caveolin-1 Inhibitors.
Sharifulina S, Khaitin A, Guzenko V, Kalyuzhnaya Y, Dzreyan V, Logvinov A
Biomedicines. 2022; 10(10).
PMID: 36289917
PMC: 9599860.
DOI: 10.3390/biomedicines10102655.
Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer's disease and normal physiology.
Pfundstein G, Nikonenko A, Sytnyk V
Front Cell Dev Biol. 2022; 10:969547.
PMID: 35959488
PMC: 9360506.
DOI: 10.3389/fcell.2022.969547.
Amylin and Secretases in the Pathology and Treatment of Alzheimer's Disease.
Singh S, Yang F, Sivils A, Cegielski V, Chu X
Biomolecules. 2022; 12(7).
PMID: 35883551
PMC: 9312829.
DOI: 10.3390/biom12070996.
I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice.
Mota B, Ashburner N, Abelleira-Hervas L, Liu L, Aleksynas R, Rovati L
Int J Mol Sci. 2022; 23(13).
PMID: 35806327
PMC: 9266435.
DOI: 10.3390/ijms23137320.
Dysregulated Ca Homeostasis as a Central Theme in Neurodegeneration: Lessons from Alzheimer's Disease and Wolfram Syndrome.
Callens M, Loncke J, Bultynck G
Cells. 2022; 11(12).
PMID: 35741091
PMC: 9221778.
DOI: 10.3390/cells11121963.
Neuroprotective effects of the extract against an Alzheimer-like rat model of β amyloid intrahippocampal injection.
NGo P, Ahami O, El Hessni A, Azzaoui F, Aboussaleh Y, Tako A
Transl Neurosci. 2022; 12(1):545-560.
PMID: 34992853
PMC: 8678622.
DOI: 10.1515/tnsci-2020-0183.
γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processing.
Weber T, Lundkvist J, Wanngren J, Kvartsberg H, Jin S, Larssen P
J Cell Mol Med. 2021; 26(3):880-892.
PMID: 34931449
PMC: 8817114.
DOI: 10.1111/jcmm.17146.
Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer's Disease.
Mamsa S, Meloni B
Front Mol Neurosci. 2021; 14:759729.
PMID: 34776866
PMC: 8581540.
DOI: 10.3389/fnmol.2021.759729.
Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer's Disease.
de Sousa N, Scotti L, de Moura E, Maia M, Rodrigues G, de Medeiros H
Curr Neuropharmacol. 2021; 20(5):857-885.
PMID: 34636299
PMC: 9881095.
DOI: 10.2174/1570159X19666211005145952.
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders.
Vishal P, Oh J, Khames A, Abdelgawad M, Sujathan Nair A, Nath L
Pharmaceutics. 2021; 13(6).
PMID: 34201128
PMC: 8226672.
DOI: 10.3390/pharmaceutics13060850.
Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer's: a Comprehensive Review.
Eskandari S, Sajadimajd S, Alaei L, Soheilikhah Z, Derakhshankhah H, Bahrami G
Neurotox Res. 2021; 39(5):1589-1612.
PMID: 34169405
DOI: 10.1007/s12640-021-00381-7.
